Home
HelpTest Code CDA7X Drug Abuse Survey with Confirmation, Panel 9, Chain of Custody, Random, Urine
Reporting Name
Confirmed Drug Abuse Panel9, CoC, UPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Useful For
Detecting drug abuse involving alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, methadone, opiates, phencyclidine, and tetrahydrocannabinol
This chain-of-custody test is intended to be used in a setting where the test results can be used definitively to make a diagnosis.
This test is not intended for use in employment-related testing.
Method Name
Enzymatic Assay/Immunoassay
Specimen Required
Container/Tube: Chain-of-Custody Kit (T282) containing the specimen containers, seals, and documentation required
Specimen Volume: 30 mL
Collection Instructions: Collect specimen in the provided container, seal, and submit with the associated documentation to satisfy the legal requirements for chain-of-custody testing.
Additional Information: Submitting less than 30 mL will compromise our ability to perform all necessary testing.
Specimen Type
UrineSpecimen Minimum Volume
15 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Urine | Refrigerated (preferred) | 7 days | |
| Frozen | 14 days |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
Negative
Screening cutoff concentrations
Amphetamines: 500 ng/mL
Barbiturates: 200 ng/mL
Benzodiazepines: 100 ng/mL
Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL
Ethanol: 10 mg/dL
Methadone metabolite: 300 ng/mL
Opiates: 300 ng/mL
Phencyclidine: 25 ng/mL
Tetrahydrocannabinol carboxylic acid: 50 ng/mL
This report is intended for use in clinical monitoring or management of patients. It is not intended for use in employment-related testing.
Interpretation
A positive result indicates that the patient has used the drugs detected in the recent past. See individual tests (eg, AMPHX / Amphetamines Confirmation, Chain of Custody, Random, Urine) for more information.
For information about drug testing, including estimated detection times, see Drugs of Abuse Testing.
Day(s) Performed
Monday through Saturday
Report Available
2 to 3 daysTest Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80307
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| CDA7X | Confirmed Drug Abuse Panel9, CoC, U | 87428-9 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 36262 | Alcohol | 42242-8 |
| 36253 | Amphetamines | 43983-6 |
| 36258 | Barbiturates | 70155-7 |
| 36259 | Benzodiazepines | 14316-4 |
| 36254 | Cocaine | 43984-4 |
| 36260 | Methadone metabolite | 41858-2 |
| 36255 | Opiates | 70151-6 |
| 36256 | Phencyclidine | 14310-7 |
| 36257 | Tetrahydrocannabinol | 14312-3 |
| 36261 | Chain of Custody | 77202-0 |
Forms
1. Chain of Custody Request is included in the Chain-of-Custody Kit (T282).
2. If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.
Additional Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| COCH | Chain of Custody Processing | No | Yes |
| ADLTX | Adulterants Survey, CoC, U | Yes | Yes |
Reflex Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| THCX | Carboxy-THC Confirmation, CoC, U | Yes | No |
| PCPX | Phencyclidine Confirmation, CoC, U | Yes | No |
| MTDNX | Methadone Confirmation, CoC, U | Yes | No |
| COKEX | Cocaine and metabolite Conf, CoC, U | Yes | No |
| BNZX | Benzodiazepines Conf, CoC, U | Yes | No |
| BARBX | Barbiturates Confirmation, CoC, U | Yes | No |
| AMPHX | Amphetamines Confirmation, CoC, U | Yes | No |
| OPATX | Opiate Confirmation, CoC, U | Yes | No |
| ETOHX | Ethanol, CoC, U | No | No |
Testing Algorithm
Testing begins with screening tests for alcohol and drugs of abuse. Positives are confirmed and quantitated by definitive methods (gas chromatography with flame ionization detector for ethanol; gas chromatography mass spectrometry for barbiturates, cocaine and metabolites, methadone, and phencyclidine) at an additional charge. Amphetamines, benzodiazepines, opiates, and tetrahydrocannabinol metabolite that screen positive will be quantified with liquid chromatography tandem mass spectrometry at an additional charge.
Adulterants testing will be performed on all chain-of-custody urine samples as per regulatory requirements.